CytoMed Therapeutics (GDTC) is pleased to announce that it entered into an At-the-Market Sales Agreement with R.F. Lafferty & Co., Inc., as the sales agent. Pursuant to the Sales Agreement, the Company may offer and sell through the Agent, ordinary shares, no par value, of the Company having an aggregate value of up to $4,304,945.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GDTC: